Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma von MONTOTO, Silvia, DAVIES, Andrew John, MATTHEWS, Janet, CALAMINICI, Maria, NORTON, Andrew J, AMESS, John, VINNICOMBE, Sarah, WATERS, Rachel, ROHATINER, Ama Z. S, LISTER, T. Andrew

Volltext

Tidal modulation of seabed light and its implications for benthic algae von Roberts, Emyr Martyn, Bowers, David George, Davies, Andrew John

Volltext

Drivers of Sex-specific Trade-offs in the Macroalga Ascophyllum nodosum von Kurr, Martyn, John Davies, Andrew

Volltext

Phase 3 trial of subcutaneous epcoritamab + R-CHOP versus R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL): EPCORE DLBCL-2 von Sehn, Laurie Helen, Chamuleau, Martine, Lenz, Georg, Clausen, Michael, Haioun, Corinne, Izutsu, Koji, Davies, Andrew John John, Zhu, Jun, Oki, Toshiko, Szafer-Glusman, Edith, Conlon, Rebekah, Chiou, Hueiyu, Ipe, David, Elliott, Brian, Wu, Jun, Salles, Gilles A.

Volltext

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma von Morschhauser, Franck, Dyer, Martin J. S., Walter, Harriet S., Danilov, Alexey V., Ysebaert, Loic, Hodson, Daniel James, Fegan, Christopher, Rule, Simon A., Radford, John, Cartron, Guillaume, Bouabdallah, Krimo, Davies, Andrew John, Spurgeon, Stephen, Rajakumaraswamy, Nishanthan, Li, Biao, Humeniuk, Rita, Huang, Xi, Bhargava, Pankaj, Jürgensmeier, Juliane M., Salles, Gilles

Volltext

Ibrutinib Plus Obinutuzumab and Venetoclax in Relapsed/Refractory Mantle Cells Lymphoma Patients, Results of the OASIS Phase I Clinical Trial von Le Gouill, Steven, Morschhauser, Franck, Bouabdallah, Krimo, Cartron, Guillaume, Casasnovas, Rene-Olivier, Milpied, Noel-Jean, Gastinne, Thomas, Davies, Andrew John, Herbaux, Charles, Chiron, David, Callanan, Mary, Rule, Simon

Volltext

Updated Preliminary Results of a Phase 1b Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination with Entospletinib in Patients with B-Cell Lymphoma von Salles, Gilles, Dyer, Martin J.S., Hodson, Daniel James, Bouabdallah, Krimo, Ysebaert, Loic, Cartron, Guillaume, Davies, Andrew John, Danilov, Alexey V, Fegan, Christopher, Kio, Ebenezer A, Huang, Xi, Mitra, Siddhartha, Rule, Simon, Morschhauser, Franck

Volltext

Idelalisib Treatment Is Associated with Improved Cytopenias in Patients with Relapsed/Refractory iNHL and CLL von O'Brien, Susan, Davies, Andrew John, Flinn, Ian W., Gopal, Ajay K, Kipps, Thomas J., Salles, Gilles A., Newcomb, Terry, Waldapfel, Christopher C., Zhang, Zhihai, Stilgenbauer, Stephan

Volltext

Idelalisib Monotherapy and Durable Responses in Patients with Relapsed or Refractory Small Lymphocytic Lymphoma (SLL) von Gopal, Ajay K, Davies, Andrew John, Flinn, Ian W., Ghia, Paolo, Goy, Andre, Salles, Gilles A., Abella, Steve, Philip, Betsy, Sorenson, Bess, Wagner-Johnston, Nina D.

Volltext

Idelalisib monotherapy and durable responses in patients with relapsed or refractory Waldenstroms Macroglobulinemia (WM) von Coutre, Steven, Leonard, John, Flowers, Christopher, Davies, Andrew John, Jurczak, Wojciech, Byrd, John C., Spurgeon, Stephen Edward Forbes, Peterman, Sissy, Holes, Leanne, Cho, Yoonjin, Sorenson, Bess, Godfrey, Wayne Russell, Gopal, Ajay K.

Volltext

Phase I study of inotuzumab ozogamicin (INO) combined with R-GDP for relapsed CD22+ B-cell non-Hodgkin lymphoma (B-NHL) von Sangha, Randeep S., Davies, Andrew John, Dang, Nam H., Ogura, Michinori, Paccagnella, M. Luisa, Ananthakrishnan, Revathi, Vandendries, Erik, Tee, Goh Yeow

Volltext

Patient-reported outcomes data from a phase 2 study of idelalisib in patients with refractory indolent B-cell non-Hodgkin lymphoma (iNHL) von Wagner-Johnston, Nina D., Gopal, Ajay K., Kahl, Brad S., De Vos, Sven, Schuster, Stephen J., Jurczak, Wojciech, Flinn, Ian, Flowers, Christopher, Martin, Peter, Viardot, Andreas, Blum, Kristie A., Goy, Andre, Davies, Andrew John, Zinzani, Pier Luigi, Dreyling, Martin H., Wagner, Lynne I., Sorensen, Bess, Godfrey, Wayne Russell, Salles, Gilles A.

Volltext

A phase III, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib (GS-1101) in combination with rituximab for previously treated indo... von Leonard, John, Zinzani, Pier Luigi, Jurczak, Wojciech, Rummel, Mathias J., Salles, Gilles A., Kimby, Eva, Arkenau, Hendrik-Tobias, Davies, Andrew John, Johnson, David Michael, Evans, Shelley, Dansey, Roger D., Godfrey, Wayne R., Kahl, Brad S.

Volltext

Effect of short-duration chemoimmunotherapy plus radioimmunotherapy on response rates in relapsed follicular lymphoma: A U.K. NCRI Lymphoma Group Study, CR UK/07/038 von Illidge, Timothy M, Bates, Andrew T., Davies, Andrew John, Pettengell, Ruth, Andrews, Barry, Dent, Louise, Hampson, Grace, Zivanovic, Maureen, Gallop-Evans, Eve, Radford, John A., Johnson, Peter W. M.

Volltext

EXPLOSION RELIEF PANELS von GILMORE, Michael Andrew, HASSON, Michael Vincent, DAVIES, Andrew John, NORRIS, Christopher

Volltext bestellen

Explosion relief panels von Michael Andrew Gilmore, Andrew John Davies, Michael Vincent Hasson, Christopher Norris

Volltext bestellen

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma von Bewicke-Copley, Findlay, Korfi, Koorosh, Araf, Shamza, Hodkinson, Brendan, Kumar, Emil, Cummin, Thomas, Ashton-Key, Margaret, Barrans, Sharon L, van Hoppe, Suzan Jl, Burton, Cathy, Elshiekh, Mohamed, Rule, Simon, Crosbie, Nicola, Clear, Andrew James, Calaminici, Maria, Runge, Hendrik Friedrich Peter, Hills, Robert K, Scott, David W, Rimsza, Lisa M, Menon, Geetha, Sha, Chulin, Davies, John, Nagano, Ai, Davies, Andrew John, Painter, Daniel, Smith, Alexandra, Gribben, John G, Naresh, Kikkeri N, Westhead, David Robert, Okosun, Jessica, Steele, Andrew J, Hodson, Daniel J, Balasubramanian, Sriram, Johnson, Peter WM, Wang, Jun, Fitzgibbon, Jude

Volltext bestellen

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type Diffuse Large B Cell Lymphoma von Bewicke-Copley, Findlay, Korfi, Koorosh, Araf, Shamza, Hodkinson, Brendan, Kumar, Emil, Cummin, Thomas, Ashton-Key, Margaret, Barrans, Sharon L, van Hoppe, Suzan JL, Burton, Cathy, Elshiekh, Mohamed, Rule, Simon, Crosbie, Nicola, Clear, Andrew James, Calaminici, Maria, Runge, Hendrik Friedrich Peter, Hills, Robert K, Scott, David W, Rimsza, Lisa M, Menon, Geetha, Sha, Chulin, Davies, John, Nagano, Ai, Davies, Andrew John, Painter, Daniel, Smith, Alexandra, Gribben, John G, Naresh, Kikkeri N, Westhead, David Robert, Okosun, Jessica, Steele, Andrew J, Hodson, Daniel J, Balasubramanian, Sriram, Johnson, Peter W. M, Wang, Jun, Fitzgibbon, Jude

Volltext bestellen

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma von Morschhauser, Franck, Dyer, Martin JS, Walter, Harriet S, Danilov, Alexey V, Ysebaert, Loic, Hodson, Daniel James, Fegan, Christopher, Rule, Simon A, Radford, John, Cartron, Guillaume, Bouabdallah, Krimo, Davies, Andrew John, Spurgeon, Stephen, Rajakumaraswamy, Nishanthan, Li, Biao, Humeniuk, Rita, Huang, Xi, Bhargava, Pankaj, Jürgensmeier, Juliane M, Salles, Gilles

Volltext bestellen

A SWITCH AND A SWITCHING SYSTEM von DAVIES ANDREW JOHN

Volltext bestellen